An observational study in Cardiovascular Risk Factor, Blood Pressure and Arterial Stiffness, sponsored by University of Edinburgh. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-24.
Sponsored by University of Edinburgh · Observational
In health, blood pressure (BP) falls at night by >10% compared with day-time values. This natural dipping pattern is important as without it there is an increased risk of cardiovascular disease (CVD). Recent evidence suggests that chronotherapy (taking anti-hypertensive medication at bedtime instead of in the morning) may enhance nocturnal BP dipping and reduce the risk of CVD events. There is therefore an urgent need to characterise diurnal BP patterns in patients who may be at risk of reduced nocturnal dipping in order to maximise protective therapy in all those who would benefit. Similarly, it has previously been demonstrated that increased arterial stiffness is associated with increased CVD risk, however little is known about whether loss of diurnal variations in arterial stiffness confer addition risk. Kidney disease is independently associated with increased CVD events, but the exact makeup of this risk is not clear. Within this heterogenous cohort several very distinct groups exist including those with acute kidney injury (AKI), chronic kidney disease (CKD), inflammatory conditions like small vessel vasculitis (SVV), and those who have either donated or received a kidney transplant. Diurnal BP and arterial stiffness patterns within these patient groups are not well characterised. The investigators will recruit patients at increased risk of CVD from the Royal Infirmary of Edinburgh Renal and Vasculitis Clinics. Participants will undergo 24-hour ambulatory BP and arterial stiffness measurement in conjunction with day- and night-time blood and urine sampling on two separate occasions. This study aims to characterise diurnal patterns of BP and arterial stiffness in patients at increased risk of CVD and compare findings with healthy controls. In doing so, the investigators aim to allow more targeted CVD risk reduction strategies and improve long-term patient outcomes.
As above
Patients will be eligible to take part in the study if they attend NHS Lothian inpatient or outpatient services and can be classified as being at increased risk of CVD. This will include, but is not limited to, the following subgroups:
Exclusion Criteria:
Healthy individuals with no known medical condition and taking no regular medication
Diagnostic Test: Assessment of 24 hour blood pressure and arterial stiffness
Individuals with acute kidney injury as defined by KDIGO criteria
Diagnostic Test: Assessment of 24 hour blood pressure and arterial stiffness
Individuals with chronic kidney disease as defined by KDIGO criteria
Diagnostic Test: Assessment of 24 hour blood pressure and arterial stiffness
Individuals with active small vessel vasculitis an diagnosed by a specialist physician
Diagnostic Test: Assessment of 24 hour blood pressure and arterial stiffness
Individuals who have received a kidney transplant
Diagnostic Test: Assessment of 24 hour blood pressure and arterial stiffness
Individuals who have donated a kidney for transplantation
Diagnostic Test: Assessment of 24 hour blood pressure and arterial stiffness
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device
Nocturnal BP dip
Percentage change between mean day-time and mean night-time blood pressure
Time frame: 24 hours
Nocturnal arterial stiffness dip
Percentage change between mean day-time and mean night-time arterial stiffness
Time frame: 24 hours
Change in urine ET-1 concentration when measured in the morning (06:00 - 12:00) and in the evening (18:00-00:00)
Measurement of urine ET-1 concentration in the morning (06:00 - 12:00) and in the evening (18:00-00:00)
Time frame: Morning (06:00-12:00) and evening (18:00-00:00)
Change in plasma ET-1 concentration when measured in the morning (06:00 - 12:00) and in the evening (18:00-00:00)
Measurement of plasma ET-1 concentration in the morning (06:00 - 12:00) and in the evening (18:00-00:00)
Time frame: Morning (06:00-12:00) and evening (18:00-00:00)
Plan to share: No — There is no plan to share IPD
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Edinburgh